Understanding the impact of long COVID in Brazil
Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil
This study looks at how long COVID affects adults in Brazil who had symptoms during the omicron wave to see what problems they face and how it impacts their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1694 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Inova Medical Academic / other |
| Locations | 1 site (Cachoeirinha, Rio Grande do Sul) |
| Trial ID | NCT05822193 on ClinicalTrials.gov |
What this trial studies
This national retrospective cohort study aims to enroll 1,694 adult patients diagnosed with COVID-19 during the omicron wave in Brazil. Participants will be recruited online and assessed for the incidence and potential risk factors associated with post-acute COVID-19 syndrome, as well as its impact on health-related quality of life. The study focuses on individuals who experienced symptomatic COVID-19 after January 2022 and evaluates outcomes at least 90 days post-diagnosis.
Who should consider this trial
Good fit: Ideal candidates are Brazilian residents aged 18 and older who had symptomatic COVID-19 confirmed by testing after January 2022.
Not a fit: Patients who are unable to participate in remote research appointments or have significant communication difficulties may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term effects of COVID-19 and inform strategies for improving patient care.
How similar studies have performed: Other studies have explored post-COVID conditions, but this specific approach focusing on the Brazilian population during the omicron wave is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years; * Brazilian resident; * Symptomatica COVID-19 confirmed by reverse transcriptase polymerase chain reaction (RT-PCR) or antigen test for SARS-COV-2 after January 2022, with diagnosis at least 90 days before recruitment. Exclusion Criteria: * No availability to participate in remote research appointments; * Communication difficulty (aphasia, important hearing loss, non-portuguese speaker, severe dementia) * Refuse to provide informed consent
Where this trial is running
Cachoeirinha, Rio Grande do Sul
- Inova Medical — Cachoeirinha, Rio Grande do Sul, Brazil (Recruiting)
Study contacts
- Study coordinator: Maicon Falavigna, MD, PhD
- Email: maicon@inovamedical.com.br
- Phone: +5551994408818
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.